Federated Hermes’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $106K | Buy |
+1,001
| New | +$88.6K | ﹤0.01% | 1581 |
|
|
2025
Q1 | – | Sell |
-7
| Closed | -$270 | – | 2177 |
|
|
2024
Q4 | $270 | Buy |
+7
| New | +$305 | ﹤0.01% | 2048 |
|
|
2023
Q4 | – | Sell |
-60,234
| Closed | -$1M | – | 2175 |
|
|
2023
Q3 | $1M | Buy |
60,234
+30,507
| +103% | +$592K | ﹤0.01% | 1110 |
|
|
2023
Q2 | $821K | Buy |
29,727
+74
| +0.2% | +$1.85K | ﹤0.01% | 1200 |
|
|
2023
Q1 | $682K | Sell |
29,653
-17,155
| -37% | -$288K | ﹤0.01% | 1305 |
|
|
2022
Q4 | $511K | Buy |
+46,808
| New | +$395K | ﹤0.01% | 1363 |
|
|
2022
Q3 | – | Sell |
-28
| Closed | -$1K | – | 2223 |
|
|
2022
Q2 | $1K | Buy |
+28
| New | +$339 | ﹤0.01% | 2071 |
|
|
2021
Q4 | – | Sell |
-131,282
| Closed | -$2.33M | – | 2287 |
|
|
2021
Q3 | $2.33M | Buy |
131,282
+69,267
| +112% | +$2.95M | ﹤0.01% | 1002 |
|
|
2021
Q2 | $2.78M | Buy |
+62,015
| New | +$2.05M | 0.01% | 995 |
|
|
2021
Q1 | – | Sell |
-42,992
| Closed | -$867K | – | 2329 |
|
|
2020
Q4 | $867K | Buy |
42,992
+42,887
| +40,845% | +$923K | ﹤0.01% | 1376 |
|
|
2020
Q3 | $2K | Buy |
+105
| New | +$1.97K | ﹤0.01% | 2104 |
|
|
2019
Q3 | – | Sell |
-304
| Closed | -$4K | – | 2276 |
|
|
2019
Q2 | $4K | Buy |
304
+130
| +75% | +$1.44K | ﹤0.01% | 2020 |
|
|
2019
Q1 | $2K | Buy |
+174
| New | +$1.54K | ﹤0.01% | 2071 |
|
|
2018
Q3 | – | Sell |
-12,682
| Closed | -$85K | – | 2314 |
|
|
2018
Q2 | $85K | Sell |
12,682
-51,239
| -80% | -$393K | ﹤0.01% | 1626 |
|
|
2018
Q1 | $549K | Buy |
63,921
+46,496
| +267% | +$876K | ﹤0.01% | 1369 |
|
|
2017
Q4 | $362K | Buy |
+17,425
| New | +$309K | ﹤0.01% | 1436 |
|
Other funds holding PTGX
FCM
RI
VPM
VCM
JJ